Tag: Jack Mycka

Indegene strengthens its Pricing, Reimbursement and Market Access capabilities with Medical Marketing Economics, LLC acquisition

August 30, 2021

Indegene, a technology-led healthcare solutions provider, today announced the acquisition of Medical Marketing Economics, LLC (MME), a global leader in Pricing, Reimbursement and Market Access (PRMA) services.

What impact will Trump’s most-favored-nation approach have on US drug pricing?

October 20, 2020

A 10-year review (2009-2018) of market access of pharmaceuticals in the EU5 and US.

December 1, 2019

Jack Mycka Teaches Pricing Short Course at ISPOR Europe 2019 in Copenhagen, November 2-6

November 5, 2019

Montclair, NJ ― November 5, 2019 ― Jack Mycka (Global President and CEO of MME, LLC), joined Renato Dellamano, Ph.D. (President of MME Europe and ValueVector, Milan, Italy), to offer a short course at ISPOR Europe 2019, held in Copenhagen, Denmark, November 2-6.

ISPOR Pricing Short Courses with Jack Mycka and Renato Dellamano at ISPOR Annual International Meeting May 2019

November 5, 2019

Market access trends across the EU5 and US: 2009 to 2018 – an update.

June 1, 2019

EU5 market access for medicines approved under exceptional circumstances.

December 1, 2018

Market access trends for advanced therapy medicinal products (ATMPs) in Europe.

December 1, 2018

EU5 market access for medicines with conditional marketing authorisations.

December 1, 2018

Jack Mycka Teaches Pricing Short Course at ISPOR Europe 2018 in Barcelona, November 10-14

November 21, 2018